T. Rowe Price Associates’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $206K | Hold |
|
|||||
|
2023
Q2 | $180K | Sell |
|
|||||
|
2023
Q1 | $265K | Hold |
|
|||||
|
2022
Q4 | $396K | Buy |
|
|||||
|
2022
Q3 | $223K | Sell |
|
|||||
|
2022
Q2 | $27.1M | Sell |
|
|||||
|
2022
Q1 | $29.7M | Sell |
|
|||||
|
2021
Q4 | $45.7M | Buy |
|
|||||
|
2021
Q3 | $50.3M | Buy |
|
|||||
|
2021
Q2 | $36.7M | Buy |
|
|||||
|
2021
Q1 | $1.68M | Buy |
|
|||||
|
2020
Q4 | $578K | Buy |
|